Market revenue in 2022 | USD 609.9 million |
Market revenue in 2030 | USD 1,373.5 million |
Growth rate | 10.7% (CAGR from 2022 to 2030) |
Largest segment | Attenuated live vaccines |
Fastest growing segment | DNA Vaccines |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines |
Key market players worldwide | Zoetis, Ceva Santé Animale, Merck & Co Inc, Vetoquinol SA, Boehringer Ingelheim, Elanco Animal Health Inc, Virbac SA, Veterinary Pharmaceutical Solutions, Dechra Pharmaceuticals, IDEXX Laboratories Inc, Norbrook |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to animal vaccines market will help companies and investors design strategic landscapes.
Attenuated live vaccines was the largest segment with a revenue share of 37.81% in 2022. Horizon Databook has segmented the China animal vaccines market based on attenuated live vaccines, inactivated vaccines, subunit vaccines, dna vaccines, recombinant vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing consumption of pork, meat, and beef and the threat from zoonotic diseases are major factors driving the growth of China animal vaccine market. Moreover, increasing initiatives being undertaken by the government and animal welfare associations to raise awareness about the numerous diseases in companion animals are expected to fuel the growth of the market.
In 2018, China undertook initiatives for educating the community about rabies prevention and established goals to complete dog vaccination registration program nationwide. Moreover, by 2020, it planned to raise the vaccinated percentage to at least 7% of the total dog population.
For instance, in 2018, Zoetis started construction of animal vaccine R&D and manufacturing facility in China to target widespread diseases in the country. The company anticipates that such vaccines will eventually become an essential health management tool in this industry. Foot-and-mouth disease is a highly infectious disease that threatens and hinders the development of the Chinese livestock sector.
Horizon Databook provides a detailed overview of country-level data and insights on the China animal vaccines market , including forecasts for subscribers. This country databook contains high-level insights into China animal vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account